406/1050 included

BCG vaccine to reduce unplanned absenteeism due to illness of health care workers during the COVID-19 pandemic

This multi-center randomized controlled trial tests whether providing Bacille Calmette-Guérin (BCG) vaccination to health care workers can protect against COVID-19. The trial is conducted by a consortium of researchers from Cape Verde, Denmark, Guinea-Bissau, Mozambique and Portugal. It began in 2020 and is expected to finish enrollments by the end of 2021 and is funded by an EDCTP grant.